{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:59:52Z","timestamp":1789498792391,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"\n Background:<\/jats:title>\n Sugammadex is a selective reversal agent which has the ability to reverse deep neuromuscular blockade. However, there are still controversial results as regard sugammadex effects on the quality of recovery. We hypothesized that Sugammadex may have better recovery profile compared to neostigmine in pediatric patients with congenital heart diseases undergoing cardiac catheterization.<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods:<\/jats:title>\n \n This prospective randomized double-blind study included 50 pediatric patients aged <2 years who were divided into two groups according to the reversal agent used; Group S (Sugammadex) and Group N (Neostigmine). Both groups received the same anesthetic technique during cardiac catheterization, and basic hemodynamic monitoring was ensured in both groups. After the procedure, reversal was done using 4 mg.kg\n [FIGURE DASH]1<\/jats:sup>\n sugammadex or 0.04 mg. kg\n [FIGURE DASH]1<\/jats:sup>\n neostigmine plus 0.02 mg. kg\n [FIGURE DASH]1<\/jats:sup>\n atropine according to the group allocation. Recovery time and side effects were recorded.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n The two groups showed comparable findings regarding demographics. Nonetheless, the total time of anesthesia had mean values of 91.06 and 101.25 min in the two groups, respectively (\n P<\/jats:italic>\n = 0.003), while recovery time had mean values of 1.61 and 9.23 min in the same groups, respectively (\n P<\/jats:italic>\n < 0.001). Hemodynamic profile (heart rate and mean arterial pressure) was better after reversal with sugammadex. Blood sugar levels and side effects showed no significant difference between both groups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Sugammadex can be a more rapid and effective alternative to neostigmine for reversal of rocuronium-induced neuromuscular blockade in pediatric patients undergoing cardiac catheterization.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/aer.aer_139_21","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T09:16:38Z","timestamp":1644830198000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Recovery Profile of Sugammadex versus Neostigmine in Pediatric Patients Undergoing Cardiac Catheterization"],"prefix":"10.4103","volume":"15","author":[{"given":"Hosam I. El Said","family":"Saber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif A.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Refaat","family":"AbouRezk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zaglool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20240901","first-page":"e698","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Stout","year":"2019","journal-title":"Circulation"},{"key":"R2-5-20240901","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11886-018-0966-y","article-title":"Transcatheter pulmonary valve replacement: Current state of art","volume":"20","author":"Alkashkari","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"R3-5-20240901","doi-asserted-by":"crossref","first-page":"503163","DOI":"10.1016\/j.mrgentox.2020.503163","article-title":"Cardiac catheterization procedures in children with congenital heart disease: Increased chromosomal aberrations in peripheral lymphocytes","volume":"852","author":"Gao","year":"2020","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"R4-5-20240901","first-page":"675","article-title":"Arrhythmia during diagnostic cardiac catheterization in pediatric patients with congenital heart disease","volume":"46","author":"Kasar","year":"2018","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R5-5-20240901","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1213\/ANE.0b013e3181c9f927","article-title":"Anesthesia-related cardiac arrest in children with heart disease: Data from the Pediatric Perioperative Cardiac Arrest (POCA) registry","volume":"110","author":"Ramamoorthy","year":"2010","journal-title":"Anesth Analg"},{"key":"R6-5-20240901","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/pan.12551","article-title":"Anesthesia and the pediatric cardiac catheterization suite: A review","volume":"25","author":"Lam","year":"2015","journal-title":"Paediatr Anaesth"},{"key":"R7-5-20240901","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1053\/j.jvca.2018.03.027","article-title":"Selected 2017 highlights in congenital cardiac anesthesia","volume":"32","author":"Nasr","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R8-5-20240901","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/pan.12413","article-title":"Patient and procedural characteristics for successful and failed immediate tracheal extubation in the operating room following cardiac surgery in infancy","volume":"24","author":"Miller","year":"2014","journal-title":"Paediatr Anaesth"},{"key":"R9-5-20240901","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bpa.2018.06.004","article-title":"Neuromuscular blockers and reversal agents and their impact on anesthesia practice","volume":"32","author":"Zafirova","year":"2018","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R10-5-20240901","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jclinane.2019.02.014","article-title":"Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study","volume":"57","author":"Kim","year":"2019","journal-title":"J Clin Anesth"},{"key":"R11-5-20240901","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1213\/ANE.0b013e3181ce8d5e","article-title":"Cochrane corner: Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade","volume":"110","author":"Abrishami","year":"2010","journal-title":"Anesth Analg"},{"key":"R12-5-20240901","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/bja\/aev437","article-title":"Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)\u2020","volume":"116","author":"Kaufhold","year":"2016","journal-title":"Br J Anaesth"},{"key":"R13-5-20240901","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/anae.14174","article-title":"Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: A randomised controlled trial","volume":"73","author":"Paech","year":"2018","journal-title":"Anaesthesia"},{"key":"R14-5-20240901","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/pan.13050","article-title":"Current evidence for the use of sugammadex in children","volume":"27","author":"Tobias","year":"2017","journal-title":"Paediatr Anaesth"},{"key":"R15-5-20240901","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ALN.0b013e318194caaa","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients","volume":"110","author":"Plaud","year":"2009","journal-title":"Anesthesiology"},{"key":"R16-5-20240901","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/ALN.0000000000002551","article-title":"The American Society of Anesthesiologists practice parameter methodology","volume":"130","author":"Apfelbaum","year":"2019","journal-title":"Anesthesiology"},{"key":"R17-5-20240901","first-page":"CD012763","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults","volume":"8","author":"Hristovska","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-5-20240901","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14740338.2019.1649393","article-title":"Safety of sugammadex for reversal of neuromuscular block","volume":"18","author":"Honing","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"R19-5-20240901","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1248\/bpb.b19-00044","article-title":"Reversibility of rocuronium-induced deep neuromuscular block with sugammadex in infants and children \u2013 A randomized study","volume":"42","author":"Matsui","year":"2019","journal-title":"Biol Pharm Bull"},{"key":"R20-5-20240901","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2174\/1381612825666190704101145","article-title":"Sugammadex for reversal of neuromuscular blockade: Uses and limitations","volume":"25","author":"Hawkins","year":"2019","journal-title":"Curr Pharm Des"},{"key":"R21-5-20240901","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0971-9784.124125","article-title":"Modes of ventilation, cerebral oximetry, and bidirectional Glenn procedure","volume":"17","author":"Kanchi","year":"2014","journal-title":"Ann Card Anaesth"},{"key":"R22-5-20240901","first-page":"762","article-title":"Comparison of reversal and adverse effects of sugammadex and combination of \u2013 Anticholinergic-Anticholinesterase agents in pediatric patients","volume":"19","author":"Ozg\u00fcn","year":"2014","journal-title":"J Res Med Sci"},{"key":"R23-5-20240901","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1053\/j.jvca.2020.08.069","article-title":"Sugammadex for fast-track surgery in children undergoing cardiac surgery: A randomized controlled study","volume":"35","author":"Li","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R24-5-20240901","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bjan.2014.03.001","article-title":"Sugammadex versus neostigmine in pediatric patients: A prospective randomized study","volume":"64","author":"Kara","year":"2014","journal-title":"Rev Bras Anestesiol"},{"key":"R25-5-20240901","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/1658-354X.154696","article-title":"Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients","volume":"9","author":"Ghoneim","year":"2015","journal-title":"Saudi J Anaesth"},{"key":"R26-5-20240901","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2147\/TCRM.S179420","article-title":"Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade","volume":"14","author":"Luo","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"R27-5-20240901","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00003643-201406001-00459","article-title":"Reversal of rocuronium-induced neuromuscular block by sugammadex in neonates","volume":"31","author":"Alonso","year":"2014","journal-title":"Eur J Anaesthesiol"},{"key":"R28-5-20240901","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1213\/01.ane.0000248224.42707.48","article-title":"Sugammadex reversal of rocuronium-induced neuromuscular blockade: A comparison with neostigmine-glycopyrrolate and edrophonium-atropine","volume":"104","author":"Sacan","year":"2007","journal-title":"Anesth Analg"},{"key":"R29-5-20240901","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/pan.12789","article-title":"The presumed central nervous system effects of rocuronium in a neonate and its reversal with sugammadex","volume":"26","author":"Langley","year":"2016","journal-title":"Paediatr Anaesth"},{"key":"R30-5-20240901","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/CEOR.S221308","article-title":"Impact of sugammadex versus neostigmine\/glycopyrrolate on perioperative efficiency","volume":"12","author":"Deyhim","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"R31-5-20240901","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/ALN.0000000000001409","article-title":"Current status of neuromuscular reversal and monitoring: Challenges and opportunities","volume":"126","author":"Brull","year":"2017","journal-title":"Anesthesiology"},{"key":"R32-5-20240901","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jclinane.2015.08.002","article-title":"Comparison of neostigmine and sugammadex for hemodynamic parameters in cardiac patients undergoing noncardiac surgery","volume":"28","author":"Kizilay","year":"2016","journal-title":"J Clin Anesth"},{"key":"R33-5-20240901","doi-asserted-by":"crossref","first-page":"275","DOI":"10.24125\/sanamed.v13i3.270","article-title":"Effect of sugammadex and neostigmine on blood glucose level: A prospective randomized controlled trial","volume":"13","author":"Yazar","year":"2018","journal-title":"Sanamed"}],"container-title":["Anesthesia Essays & Researches"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aer.aer_139_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:09:52Z","timestamp":1787166592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aer.aer_139_21"}},"subtitle":["A Randomized Double-Blind Study"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/aer.aer_139_21","relation":{},"ISSN":["0259-1162"],"issn-type":[{"value":"0259-1162","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}